Sorrento Therapeutics and Mount Sinai join forces to develop Covid-19 antibody shield
The two organizations are working on a treatment, called COVI-SHIELD, to be offered as a prophylactic for those returning to work and as a therapeutic to those who have been exposed to SARS-CoV-2. read here